Genomed Spólka Akcyjna (WSE: GEN)
Health Care · Biotechnology · PL
zł38.60
-3.50% today · +33.1% 1Y
Genomed Spólka Akcyjna (WSE: GEN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $13.14M.
Over the last twelve months the share price has gained 33.1%, trading between 15.40 and 43.00.
Tweenvest scores Genomed Spólka Akcyjna across four factors: quality 80/100, value 62/100, growth 84/100, dividend 100/100. Its strongest factor is dividend.
GEN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.14M
- Revenue (TTM)
- $8.14M
- P/E
- 14.55
- EPS
- 2.65
- Dividend yield
- 3.89%
- Beta (5Y)
- 0.04
- 52-week high
- zł43.00
- 52-week low
- zł15.40
- Avg volume (3M)
- —
- Shares outstanding
- 1.32M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BioCardia, Inc.NasdaqCM: BCDA | $13.93M | $0.92 | -11.53% |
| Biophytis S.A.ENXTPA: ALBPS | $13.57M | €0.03 | +8.81% |
| Genflow Biosciences plcLSE: GENF | $13.22M | £0.02 | -1.41% |
| Alzinova AB (publ)OM: ALZ | $13.21M | Skr0.43 | -1.96% |
| Imugene LimitedASX: IMU | $13.09M | AU$0.04 | -2.56% |
| TME Pharma N.V.ENXTPA: ALTME | $13.07M | €0.12 | +12.32% |
| Genomtec S.A.WSE: GMT | $12.72M | zł2.90 | -5.70% |
| Algorae Pharmaceuticals LimitedASX: 1AI | $12.70M | AU$0.01 | +12.50% |
Figures last refreshed Oct 18, 2026.